12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Ildong, Shionogi sales and marketing update

Shionogi said Ildong launched Pirespa pirfenidone in South Korea to treat idiopathic pulmonary fibrosis (IPF). Ildong has exclusive rights to market the product in South Korea from Shionogi under a 2011 deal. Shionogi...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >